Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) were down 4% on Friday . The stock traded as low as $11.03 and last traded at $11.03. Approximately 446,428 shares changed hands during mid-day trading, a decline of 29% from the average daily volume of 628,771 shares. The stock had previously closed at $11.49. […]
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have updated their coverage on […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 6,650,000 shares, an increase of 27.6% from the November 30th total of 5,210,000 shares. Based on an average daily volume of 777,800 shares, […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 6,650,000 shares, a growth of 27.6% from the November 30th total of 5,210,000 shares. Based on an average daily volume of 777,800 shares, […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]